Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT).
作者信息
Gilchrist Mark, Jamieson Conor, Drummond Felicity, Hills Tim, Seaton R Andrew, Santillo Mark
机构信息
Department of Pharmacy/Infection, Imperial College Healthcare NHS Trust, London, UK.
NHS England, Birmingham, UK.
出版信息
JAC Antimicrob Resist. 2023 Apr 17;5(2):dlad047. doi: 10.1093/jacamr/dlad047. eCollection 2023 Apr.
Abstract
摘要
相似文献
1
Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT).通过门诊胃肠外抗菌治疗（OPAT）对用于持续输注的弹性装置中头孢洛赞/他唑巴坦的降解情况和毒性数据进行评估。
JAC Antimicrob Resist. 2023 Apr 17;5(2):dlad047. doi: 10.1093/jacamr/dlad047. eCollection 2023 Apr.
2
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.头孢洛扎/他唑巴坦在弹性装置中的稳定性评估及其通过门诊胃肠外抗菌治疗进行持续输注的适用性评估。
JAC Antimicrob Resist. 2021 Sep 27;3(3):dlab141. doi: 10.1093/jacamr/dlab141. eCollection 2021 Sep.
3
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards.基于英国国家医疗服务体系黄色封面文件标准的门诊患者肠外抗菌治疗服务用弹性装置中抗菌药物稳定性的系统评价。
Eur J Hosp Pharm. 2022 Nov;29(6):304-307. doi: 10.1136/ejhpharm-2021-002729. Epub 2021 May 14.
4
Ceftolozane-tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study.弹性输注装置中的头孢洛扎他唑巴坦用于门诊治疗的体外稳定性研究。
Eur J Hosp Pharm. 2020 Mar;27(e1):e84-e86. doi: 10.1136/ejhpharm-2019-002093. Epub 2019 Dec 16.
5
Outpatient Parenteral Antimicrobial Therapy With Ceftolozane/Tazobactam via Continuous Infusion for Multidrug-Resistant Osteomyelitis.通过持续输注使用头孢洛扎/他唑巴坦进行门诊胃肠外抗菌治疗耐多药骨髓炎
Open Forum Infect Dis. 2020 Sep 15;7(11):ofaa409. doi: 10.1093/ofid/ofaa409. eCollection 2020 Nov.
6
Outpatient parenteral antibiotic therapy (OPAT) through elastomeric continuous infusion pumps in a real-life observational study: Characteristics, safety, and efficacy analysis.在一项真实世界观察性研究中，通过弹性连续输注泵进行门诊胃肠外抗生素治疗（OPAT）：特征、安全性及疗效分析。
Enferm Infecc Microbiol Clin (Engl Ed). 2024 Dec;42(10):581-587. doi: 10.1016/j.eimce.2024.04.007. Epub 2024 Jun 19.
7
Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements.评估两种市售弹性贮液袋在用于门诊患者肠外抗菌药物化疗的连续输注时，枸橼酸缓冲哌拉西林/他唑巴坦的稳定性：符合国民保健制度黄色封面文件要求的研究。
Eur J Hosp Pharm. 2022 Jul;29(4):212-216. doi: 10.1136/ejhpharm-2020-002340. Epub 2020 Sep 25.
8
Stability of antimicrobial agents in an elastomeric infusion pump used for outpatient parenteral antimicrobial therapy.弹性输注泵用于门诊肠外抗菌治疗时抗菌药物的稳定性。
Int J Infect Dis. 2021 Feb;103:464-468. doi: 10.1016/j.ijid.2020.11.176. Epub 2020 Nov 24.
9
[The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan].[日本首次采用持续输注法进行门诊胃肠外抗菌治疗（OPAT）的试验]
Kansenshogaku Zasshi. 2014 May;88(3):269-74. doi: 10.11150/kansenshogakuzasshi.88.269.
10
Evaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy.阿昔洛韦在用于门诊胃肠外抗菌治疗的弹性输液装置中的稳定性评估。
Eur J Hosp Pharm. 2025 Apr 23;32(3):272-277. doi: 10.1136/ejhpharm-2023-003784.
引用本文的文献
1
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.门诊患者的肠外抗菌治疗的现状和挑战：叙事性综述。
J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177.
本文引用的文献
1
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.头孢洛扎/他唑巴坦在弹性装置中的稳定性评估及其通过门诊胃肠外抗菌治疗进行持续输注的适用性评估。
JAC Antimicrob Resist. 2021 Sep 27;3(3):dlab141. doi: 10.1093/jacamr/dlab141. eCollection 2021 Sep.
2
Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literature.连续输注头孢他啶/他唑巴坦治疗耐药革兰氏阴性菌感染的应用：回顾性分析及文献复习。
Int J Antimicrob Agents. 2020 Nov;56(5):106158. doi: 10.1016/j.ijantimicag.2020.106158. Epub 2020 Sep 9.
3
Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting.门诊环境中持续输注头孢洛扎/他唑巴坦的临床与安全性评估。
Open Forum Infect Dis. 2020 Jan 12;7(2):ofaa014. doi: 10.1093/ofid/ofaa014. eCollection 2020 Feb.
4
OPAT in Switzerland: single-center experience of a model to treat complicated infections.瑞士的 OPAT：治疗复杂感染的模型的单中心经验。
Infection. 2020 Apr;48(2):231-240. doi: 10.1007/s15010-019-01381-8. Epub 2019 Dec 11.
5
Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.教学医院实践中的门诊患者的肠外抗菌治疗（OPAT）：一项回顾性队列研究，描述了 10 年来的经验和演变。
Int J Antimicrob Agents. 2012 May;39(5):407-13. doi: 10.1016/j.ijantimicag.2012.01.016. Epub 2012 Mar 23.
Zotero 插件